Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | JAGX | Stock option (right to buy) | Award | $0 | +26.5K | $0.00 | 26.5K | Oct 8, 2024 | Common Stock | 26.5K | $1.29 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | Granted pursuant to the issuer's 2014 Stock Incentive Plan. |
F2 | The option grant was approved by the issuer's board of directors on October 8, 2024. |
F3 | The options will vest 100% on the first anniversary of the grant date, so long as the reporting person continues to serve on the board of directors of the issuer and Napo Therapeutics, S.p.A., the issuer's subsidiary, as applicable. |